Cargando…
Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
Autores principales: | Polansky, Hanan, Itzkovitz, Edan, Javaherian, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365573/ https://www.ncbi.nlm.nih.gov/pubmed/30725243 http://dx.doi.org/10.1186/s40169-019-0222-0 |
Ejemplares similares
-
Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
por: Polansky, Hanan, et al.
Publicado: (2016) -
Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir
por: Polansky, Hanan, et al.
Publicado: (2016) -
Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes
por: Polansky, Hanan, et al.
Publicado: (2018) -
Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus
por: Polansky, Hanan, et al.
Publicado: (2017) -
Effects of Gene-Eden-VIR and Novirin on SARS-CoV:
Implications for COVID-19
por: Polansky, Hanan, et al.
Publicado: (2020)